582
Views
5
CrossRef citations to date
0
Altmetric
Review

Inhaler technique in asthma and COPD: challenges and unmet knowledge that can contribute to suboptimal use in real life

ORCID Icon
Pages 991-1003 | Received 16 Feb 2021, Accepted 11 May 2021, Published online: 13 Aug 2021

References

  • Global initiative for chronic obstructive lung disease: pocket guide to COPD diagnosis, management and prevention Available on: http://www.goldcopd.org Last access: January 2021.
  • Global Initiative for Asthma (GINA). Global strategy for asthma Management and Prevention 2017, http://www.ginasthma.org Last access: Jan 2021.
  • Wachtel H, Kattenbeck S, Dunne S, et al. The Respimat® development story: patient-centered innovation. Pulmonary Therapy. 2017;3(1).
  • Sanchis J, Gich I, Pedersen S, et al. Systematic review of errors in inhaler use: has patient technique improved over time? Chest. 2016;150:394-406.
  • Melani AS, Zanchetta D, Barbato N, et al., for the Associazione Italiana Pneumologi Ospedalieri Educational Group. Inhalation technique and variables associated with misuse of conventional metered-dose inhalers and newer dry powder inhalers in experienced adults. Ann Allergy Asthma Immunol. 2004;93(5):439–446.
  • Melani AS, Bonavia M, Cilenti V, et al., Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med. 2011;105(6): 930–988.
  • Levy ML, Hardwell A, McKnight E, et al. Asthma patients’ inability to use a pressurised metered-dose inhaler (pMDI) correctly correlates with poor asthma control as defined by the Global Initiative for Asthma (GINA) strategy: a retrospective analysis. Prim Care Respir J. 2013;22(4):406–411.
  • Molimard M, Raherison C, Lignot S, et al. Chronic obstructive pulmonary disease exacerbation and inhaler device handling: real life assessment of 2935 patients. European Respiratory Journal. 2017;49(2):1601794. .
  • Price DB, Román-Rodríguez M, McQueen RB, et al., Inhaler errors in the CRITIKAL Study: type, frequency, and association with asthma outcomes. The Journal of Allergy and Clinical Immunology: In Practice. 5(4): 1071–1081. 2017. .
  • Kocks JWH, Chrystyn H, Van Der Palen J, et al. Systematic review of association between critical errors in inhalation and health outcomes in asthma and COPD. NPJ Prim Care Respir Med. 2018 16;28(1):43. .
  • Usmani OS, Lavorini F, Marshall J, et al. Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes. Respiratory Research. 2018;19(1):10. .
  • Volerman A, Carpenter D, Press V. What can be done to impact respiratory inhaler misuse: exploring the problem, reasons, and solutions. Expert Rev Respir Med. 2020 Aug;14(8):791–805. . PMID: 32306774.
  • Molimard M, Raherison C, Lignot S, et al. Assessment of handling of inhaler devices in real life: an observational study in 3811 patients in primary care. PMID: 14572322 J Aerosol Med. 2003;163:249–254.
  • Cho-Reyes S, Celli BR, Dembek C, et al. Inhalation Technique Errors with Metered-Dose Inhalers Among Patients with Obstructive Lung Diseases: a Systematic Review and Meta-Analysis of U.S. Studies. Chronic Obstr Pulm Dis. 2019 Jul 24;6(3):267–280. . PMID: 31342732.
  • Navaie M, Dembek C, Cho-Reyes S, et al. Device use errors with soft mist inhalers: a global systematic literature review and meta-analysis. Chron Respir Dis. 2020 Jan-Dec;17( 1479973119901234. . PMID: 31984767):147997311990123. .
  • McIvor RA, Devlin HM, Kaplan A. Optimizing the Delivery of Inhaled Medication for Respiratory Patients: the Role of Valved Holding Chambers. Can Respir J. 2018 Apr 4;2018:5076259.
  • Vincken W, Levy ML, Scullion J, et al. Spacer devices for inhaled therapy: why use them, and how? ERJ Open Res. 2018 Jun 18;4(2):00065–2018. . PMID: 29928649.
  • Cyr TD, Graham SJ, Li RKY, et al. Low first-spray drug content in albuterol metered-dose inhalers. Pharm Res. 1991;8(5):658–660.
  • Chierici V, Cavalieri L, Piraino A, et al. Consequences of not-shaking and shake-fire delays on the emitted dose of some commercial solution and suspension pressurized metered dose inhalers. Expert Opin Drug Deliv. 2020 Jul;17(7):1025–1039. PMID: 32551990.
  • Hatley RH, Parker J, Pritchard JN, et al. Variability in delivered dose from pressurized Metered-Dose Inhaler formulations due to a delay between shake and fire. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 2017;30(1):71–79.
  • Laube BL, Janssens HM, Fhc DJ, et al. What the pulmonary specialist should know about the new inhalation therapies. Eur Respir J. 2011;37:1308-1331.
  • Doty A, Schroeder J, Vang K, et al. Drug delivery from an innovative LAMA/LABA co-suspension delivery technology fixed-dose combination MDI: evidence of consistency, robustness, and reliability. AAPS PharmSciTech. 2018;19(2):837–844. .
  • Ding B, Siddiqui S, DePietro M, et al. Inhaler usability of a pressurized metered dose inhaler and a soft mist inhaler in patients with COPD: a simulated-use study. Chron Respir Dis. 2019;16:1479972318787914.
  • Mvc DO, Pizzichini E, Da Costa CH, et al. Evaluation of the preference, satisfaction and correct use of Breezhaler® and Respimat® inhalers in patients with chronic obstructive pulmonary disease—INHALATOR study. Respir Med. 2018;144:61–67.
  • Dhand R, Eicher J, Hansel M, et al. Improving usability and maintaining performance: human-factor and aerosol-performance studies evaluating the new reusable Respimat inhaler. Int J COPD. 2019;14:509–523.
  • Cvetkovski B, Hespe C, Tan R, et al. General Practitioner Use of Generically Substitutable Inhaler Devices and the Impact of Training on Device Mastery and Maintenance of Correct Inhaler Technique. PMID: 33038005 Pulm Ther. 2020;62:315–331.
  • Janson C, Lööf T, Telg G, et al. Impact of inhalation flow, inhalation volume and critical handling errors on delivered budesonide/formoterol dose in different inhalers: an in vitro study. Pulmonary Therapy. 2017;3(1):243–253. .
  • Chorao P, Pereira AM, Fonseca JA. Inhaler devices in asthma and COPD - an assessment of inhaler technique and patient preferences. Respir Med. 2014;108:968–975.
  • Voshaar T, Spinola M, Linnane P, et al. Comparing usability of NEXThaler with other inhaled corticosteroid/long-acting beta2-agonist fixed combination dry powder inhalers in asthma patients. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 2014;27(5):363–370. .
  • Van Der Palen J, Thomas M, Chrystyn H, et al. A randomised open-label cross-over study of inhaler errors, preference and time to achieve correct inhaler use in patients with COPD or asthma: comparison of ELLIPTA with other inhaler devices. NPJ Prim Care Respir Med. 2016 Nov 24;26(1):16079. PMID: 27883002.
  • Sandler N, Holländer J, Långström D, et al. Evaluation of inhaler handling-errors, inhaler perception and preference with Spiromax, Easyhaler and Turbuhaler devices among healthy Finnish volunteers: a single site, single visit crossover study (Finhaler). BMJ Open Respir Res. 2016;3(1):e000119. .
  • Price DB, Thomas V, Dekhuijzen PN, et al. Evaluation of inhaler technique and achievement and maintenance of mastery of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in adult patients with asthma: the Easy Low Instruction Over Time (ELIOT) study. BMC Pulmonary Medicine. 2018;18(1):107. .
  • Giner J, Villarnovo Cerrillo M, Aboín Sierra J, et al. Assessment of inhalation errors, training time and patient preference for DuoResp® Spiromax® and Symbicort® Turbuhaler® in patients with asthma and COPD. European Clinical Respiratory Journal. 2020 Oct 18;7(1):1833411. . PMID: 33144930.
  • Kondo T, Tanigaki T, Yokohama H, et al. Impact of holding position during inhalation on drug release from a reservoir-, blister- and capsule-type dry powder inhaler. J Asthma. 2017;54(8):792–797. PMID: 27929704.
  • Sulaiman I, Seheult J, Sadasivuni N, et al. The impact of common inhaler errors on drug delivery: investigating critical errors with a dry powder inhaler. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 2017;30(4):247–255. .
  • Canonica GW, Arp J, Keegstra JR, et al. Spiromax, a New Dry Powder Inhaler: dose Consistency under Simulated Real-World Conditions. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 2015;28(5):309–319.
  • Newman SP, Pavia D, Garland N, et al. Effects of various inhalation modes on the deposition of radioactive pressurized aerosols. Eur Respir J Dis. 1982;63(Suppl. 119):57–65.
  • Hindle M, Newton DAG, Chrystyn H. Investigations of an optimal inhaler technique with the use of urinary excretion as a measure of relative bioavailability to the lung. Thorax. 1993;48:607-610.
  • Engel T, Scharling B, Skovsted B, et al. Effects, side effects and plasma concentrations of terbutaline in adult asthmatics after inhaling from a dry powder inhaler device at different inhalation flows and volumes. Br J Clin Pharmacol. 1992;33:439-444.
  • Farkas A, Lewis D, Church T, et al. Experimental and computational study of the effect of breath-actuated mechanism built in the NEXThaler() dry powder inhaler. Int J Pharm. 2017 Nov 25;533(1):225–235. PMID: 28941830.
  • Everard ML, Devadason SG, Summers QA, et al. Factors affecting total and “respirable” dose delivered by a salbutamol metered dose inhaler. Thorax. 1995;50(7):746–749.
  • Giraud V, Roche N. Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability. Eur Respir J. 2002;19:246-251.
  • Leach CL, Davidson PJ, Boudreau RJ. Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone. European Respiratory Journal. 1998;12(6):1346–1353.
  • Newman SP, Steed KP, Hooper G, et al. Lung deposition of pressurized terbutalene sulphate aerosols compared by two techniques. J Aerosol Med. 1994;7:177-179.
  • Hira D, Okuda T, Mizutani A, et al. Is “Slow Inhalation” Always Suitable for Pressurized Metered Dose Inhaler? AAPS PharmSciTech. 2020 Jan 6;21(2):53. . PMID: 31907655.
  • Usmani OS, Biddiscombe MF, Barnes PJ. Regional lung deposition and bronchodilator response as a function of beta2-agonist particle size. Am J Respir Crit Care Med. 2005;172(12):1497–1504.
  • Chhabra SK. A comparison of “closed” and “open” mouth techniques of inhalation of a salbutamol metered-dose inhaler. J Asthma. 1994;31(2):123–125.
  • Khajeh-Hosseini-Dalasm N, Longest PW. Deposition of particles in the alveolar airways: inhalation and breath-hold with pharmaceutical aerosols. J Aerosol Sci. 2015;79:15–30.
  • Hira D, Koide H, Nakamura S, et al. Assessment of inhalation flow patterns of soft mist inhaler co-prescribed with dry powder inhaler using inspiratory flow meter for multi inhalation devices. PLoS One. 2018 Feb 20;13(2):e0193082. PMID: 29462195.
  • Brand P, Hederer B, Lowe L, et al. Flussabhängigkeit der lungendeposition nach inhalation von einem HFA-dosier aerosol und dem Respimat® Soft Inhaler bei COPD patienten. Pneumologie. 2007;61:127.
  • Brand P. Higher lung deposition with Respimat® Soft Mist™ Inhaler than HFA-MDI in COPD patients with poor technique. International Journal of Chronic Obstructive Pulmonary Disease. 2008;3(4):763–770.
  • Azouz W, Chetcuti P, Hosker HS, et al. The inhalation characteristics of patients when they use different dry powder inhalers. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 2015;28(1):35–42.
  • Pedersen S, Hansen OR, Fuglsang G. Influence of inspiratory flow rate upon the effect of a Turbuhaler. Arch Dis Child. 1990;65:308-310.
  • Van Der Palen J. Peak inspiratory flow through Diskus and Turbuhaler, measured by means of a peak inspiratory flow meter (In-Check Dial). Respir Med. 2003;97:285–289.
  • Melani AS, Bracci LS, Rossi M. Reduced Peak Inspiratory effort through the Diskus® and the Turbuhaler® due to mishandling is common in clinical practice. Clin Drug Investig. 2005;25(8):543–549.
  • Mahler DA, Waterman LA, Gifford AH. Prevalence and COPD phenotype for a suboptimal peak inspiratory flow rate against the simulated resistance of the Diskus® dry powder inhaler. J Aerosol Med Pulm Drug Deliv. 2013;26(3):174–179.
  • Altman P, Wehbe L, Dederichs J, et al. Comparison of peak inspiratory flow rate via the Breezhaler®, Ellipta® and HandiHaler® dry powder inhalers in patients with moderate to very severe COPD: a randomized cross-over trial. BMC Pulm Med. 2018 Jun 14;18(1):100. PMID: 29898702.
  • Sulaiman I, Cushan B, Greene G, et al. Objective assessment of adherence to inhalers by patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2017;195(10):1333–1343. .
  • Hawksworth GM, James L, Chrystyn H. Characterization of the inspiratory manoeuvre when asthmatics inhale through a Turbohaler pre- and post-counselling in a community pharmacy. Respir Med. 2000;94(5):501–504.
  • Al-Showair R, Tarsin W, Assi K, et al. Can all patients with COPD use the correct inhalation flow with all inhalers and does training help? Respir Med. 2007;101(11):2395–2401.
  • Magnussen H, Watz H, Zimmermann I, et al. Peak inspiratory flow through the Genuair inhaler in patients with moderate or severe COPD. Respiratory Medicine. 2009;103(12):1832–1837.
  • Kondo T, Tanigaki T, Hibino M, et al. IS IT NECESSARY TO PROHIBIT SIDE-HOLE CLOSURE IN USE OF THE DRY POWDER INHALERS? PMID: 30867367 Arerugi. 2019;682:96–100.
  • Everard ML, Devadason SG, Le Souëf PN. Flow early in the inspiratory manoeuvre affects the aerosol particle size distribution from a Turbuhaler. Respiratory Medicine. 1997;91(10):624–628.
  • Haikarainen J, Rytilä P, Roos S, et al. Dose uniformity of budesonide Easyhaler® under simulated real-life conditions and with low inspiration flow rates. 1479972317745733 Chron Respir Dis. 2017;153:265–271.
  • Al-Fadhi SA, Assi KH, Clark BJ, et al. Tiotropium dose emission is influenced by the inhalation flow and the recommended two inhalations for each dose. Eur Respir J. 2005;26(Suppl. 49):125s–6S.
  • Abadelah M, Chrystyn H, Bagherisadeghi G, et al. Study of the Emitted Dose After Two Separate Inhalations at Different Inhalation Flow Rates and Volumes and an Assessment of Aerodynamic Characteristics of Indacaterol Onbrez Breezhaler®150 and 300 μg. AAPS PharmSciTech. 2018;19(1):251–261.
  • Ali AMA, Zawbaa HM, Sayed OM, et al. In vitro and in vivo performance modelling and optimisation of different dry powder inhalers: a complementary study of neural networks, genetic algorithms and decision trees. Int J Clin Pract. 2020 Oct 17;75(3):e13764. PMID: 33067907.
  • Kondo T, Hibino M, Tanigaki T, et al. Exhalation immediately before inhalation optimizes dry powder inhaler use. PMID: 26513654 J Asthma. 2015;529:935–939.
  • Tajiri S, Kondo T, Tanigaki T, et al. Analysis of Drug Release Dynamics of the Reservoir-type Dry Powder Inhalers Tokai. J Exp Clin Med. 2020;45(3):102–107.
  • Buttini F, Brambilla G, Copelli D, et al. Effect of flow rate on in vitro aerodynamic performance of NEXThaler® in comparison with Diskus® and Turbohaler® Dry Powder Inhaler. J Aerosol Med Pulm Drug Deliv. 2016 Apr;29(2):167–178.
  • Given J, Taveras H, Iverson H, et al. Prospective, open-label assessment of albuterol sulfate hydrofluoroalkane metered-dose inhaler with new integrated dose counter. Allergy Asthma Proc. 2013;34(1):42–51.
  • Storms WW, Tringale M, Ferro TJ. The impact of expired and empty quick-relief asthma inhalers: the Asthma and Allergy Foundation of America’s Asthma Inhaler Design Survey. Allergy Asthma Proc. 2015 Jul-Aug;36(4):300–305. PMID: 25916212.
  • Db P, Rigazio A, Small M, et al. Historical cohort study examining comparative effectiveness of albuterol inhalers with and without integrated dose counter for patients with asthma or chronic obstructive pulmonary disease. J Asthma Allergy. 2016 Aug 26;9:145–154.
  • Norderud Lærum B, Telg G, Stratelis G. Need of education for dry powder inhaler storage and retention - a patient-reported survey. Multidiscip Respir Med. 2016;11:21.
  • Ruzycki CA, Martin AR, Finlay WH. An Exploration of Factors Affecting In Vitro Deposition of Pharmaceutical Aerosols in the Alberta Idealized Throat. J Aerosol Med Pulm Drug Deliv. 2019 Dec;32(6):405–417. PMID: 31418632.
  • Morin CMD, Ivey JW, Titosky JTF, et al. Pressurized metered-dose inhalers at extreme temperature conditions. Journal of Pharmaceutical Sciences. 2014;103(11):3553–3559.
  • Shemirami FM, Hoe S, Lewis D, et al. In vitro investigation of the effect of ambient humidity on regional delivered dose with solution and suspension MDIs. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 2013;26(4):215–222.
  • Lindsay DA, Russell NL, Thompson JE, et al. A multicentre comparison of the efficacy of terbutaline turbuhaler and salbutamol pressurized metered dose inhaler in hot, humid regions. European Respiratory Journal. 1994;7(2):342–345.
  • Yu J, Wong J, Ukkonen A, et al. Effect of Relative Humidity on Bipolar Electrostatic Charge Profiles of dry Powder Aerosols. Pharm Res. 2017 Aug;34(8):1707–1715. PMID: 28540500.
  • Borgstrom L, Asking L, Lipniunas P. An in vivo and in vitro comparison of two powder inhalers following storage at hot/humid conditions. J Aerosol Med. 2005;18:304-310.
  • Janson C, Lööf T, Telg G, et al. Difference in resistance to humidity between commonly used dry powder inhalers: an in vitro study. NPJ Prim Care Respir Med. 2016;26:16053.
  • Haikarainen J, Selroos O, Löytänä T, et al. Budesonide/formoterol Easyhaler®: performance under simulated real-life conditions. Pulmonary Therapy. 2017;3(1):125–138. .
  • Turpeinen A, Eriksson P, Happonen A, et al. Consistent Dosing Through the Salmeterol-Fluticasone Propionate Easyhaler for the Management of Asthma and Chronic Obstructive Pulmonary Disease: robustness Analysis Across the Easyhaler Lifetime. J Aerosol Med Pulm Drug Deliv. 2020 Sep 22. PMID: 32960127. 10.1089/jamp.2020.1592
  • Renswouw DC, Laarhoven AC, Haren MJ, et al. Storage instructions for inhalation capsules: consequences of incorrect storage and adherence in daily practice. Journal of Pharmacy Practice. 2010;23(6):548–552.
  • Harb HS, Laz NI, Rabea H, et al. First-time handling of different inhalers by chronic obstructive lung disease patients. Exp Lung Res. 2020 Sep;46(7):258–269. . PMID: 32614625.
  • Sestini P, Cappiello V, Aliani M, et al.; on behalf of the Associazione Italiana Pneumologi Ospedalieri (AIPO) Educational Group. Prescription bias and factor associated with improper use of inhalers. J Aerosol Med. 2006;19:127–136.
  • Press VG, Arora VM, Shah LM, Press VG, Arora VM, Shah LM, et al. Teaching the use of respiratory inhalers to hospitalized patients with asthma or COPD: a randomized trial. J Gen Intern Med. 2012;27(10):1317–1325. .
  • Klijn SL, Hiligsmann M, Evers SMAA, et al. Effectiveness and success factors of educational inhaler technique interventions in asthma & COPD patients: a systematic review. NPJ Prim Care Respir Med. 2017 Apr 13;27(1):24. . PMID: 28408742.
  • Elgendy MO, Abdelrahim ME, Eldin RS. Potential Benefit of Repeated Dry Powder Inhaler’s Inhalation Technique Counseling on Asthmatic Patients. Pulm Ther. 2015;1:91–101.
  • Abdelrahman MA, Saeed H, Osama H, et al. Effect of verbal counselling on metred-dose inhaler proper use and lung function test amongst asthmatic patients: a meta-analysis. Int J Clin Pract. 2021 Feb 7:e14077 PMID: 33550651. doi:10.1111/ijcp.14077.
  • Lavorini F, Ml L, Corrigan C, et al.; ADMIT Working Group. The ADMIT series - issues in inhalation therapy. 6) Training tools for inhalation devices. Prim Care Respir J. 2010 Dec;19(4):335–341. PMID: 21049263.
  • Carpenter DM, Roberts CA, Sage AJ, et al. Review of Electronic Devices to Assess Inhaler Technique. Curr Allergy Asthma Rep. 2017 Mar;17(3):17. . PMID: 28290015.
  • Dundon A, Cipolla D, Mitchell J, et al. Reflections on Digital Health Tools for Respiratory Applications. J Aerosol Med Pulm Drug Deliv. 2020 Jun;33(3):127–132. . PMID: 32176547.
  • Müller T, Müller A, Hübel C, et al. Optimizing inhalation technique using web-based videos in obstructive lung diseases. Respir Med. 2017;129:140–144.
  • Dhadge N, Shevade M, Kale N, et al. Monitoring of inhaler use at home with a smartphone video application in a pilot study. NPJ Prim Care Respir Med. 2020 Oct 16;30(1):46. PMID: 33067469.
  • Vg P, Vm A, Ca K, et al. Effectiveness of virtual vs in-person inhaler education for hospitalized patients with obstructive lung disease: a randomized clinical trial. JAMA Network Open. 2020;3(1):e1918205. .
  • Eudaley ST, Dabbs WS, Chamberlin SM. YouTube as a Guide for Respimat Soft Mist Inhaler Technique. J Pharm Pract. 2019 Jun 23 897190019853988. . PMID: 31232147;34(1):40–43…
  • Kafaei Shirmanesh Y, Jones MD. Physical ability of people with rheumatoid arthritis and age-sex matched controls to use four commonly prescribed inhaler devices. Respir Med. 2018;135:12–14.
  • Iwata Y, Kakuta S, Osawa S, et al. Relationship between cognitive function and proper inhaler device use in elderly patients. Eur Respir J. 2019;54.
  • Schnell K, Weiss CO, Lee T, et al. The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999–2008. BMC Pulm Med. 2012;12(1):26.
  • Hirose M, Kondo R, Horiguchi T. Use of Assist Devices to Actuate Pressurized Metered-Dose Inhalers in Elderly Patients with Asthma. Pulm Ther. 2021 Feb 6. PMID: 33548048. doi:10.1007/s41030-021-00146-9
  • on beahlf of the Gruppo Educazionale Associazione Italiana Pneumologi Ospedalieri (AIPO), Melani AS, Bonavia M, Mastropasqua E, et al. Time required to rectify inhaler errors among experienced subjects with faulty technique. Respiratory Care. 2017;62(4):409–414.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.